CONSHOHOCKEN, Pa., Jan. 5, 2026 /PRNewswire/ — Tiger BioSciences today announced the official launch of its Dermatology Division, marking a significant expansionCONSHOHOCKEN, Pa., Jan. 5, 2026 /PRNewswire/ — Tiger BioSciences today announced the official launch of its Dermatology Division, marking a significant expansion

Tiger BioSciences Announces Launch of New Dermatology Division, Expanding Access to Advanced Wound Care and Aesthetic Solutions

CONSHOHOCKEN, Pa., Jan. 5, 2026 /PRNewswire/ — Tiger BioSciences today announced the official launch of its Dermatology Division, marking a significant expansion of the company’s wound care and aesthetic footprint. This new division will provide dermatologists nationwide with direct access to Tiger Wound Care’s advanced placental-derived wound care tissue products, HealPack™ surgical dressings, and Tiger Aesthetics’ cosmetic portfolio.

The launch represents a strategic step in Tiger BioSciences’ mission to deliver innovative, science-backed solutions that support both medical and cosmetic dermatology. By taking advantage of the patient care synergies between wound care and aesthetics offerings in a dedicated dermatology focused division, the company aims to streamline access, enhance clinical support, and help patients and providers across practices ranging from acute and chronic wounds to aesthetic and cosmetic treatments.

“Dermatologists are uniquely positioned at the intersection of wound and aesthetic treatments, and our new Dermatology Division is designed to meet their needs,” said Scott Madden, Co-CEO of Tiger BioSciences. “By bringing together our placental wound care technologies, HealPack surgical dressings, and our robust aesthetic product line, we’re delivering a comprehensive suite of solutions that elevate patient outcomes across the full spectrum of dermatologic care.”

The division operates with a separate distribution channel and focuses on specialized education and clinical resources tailored specifically to dermatology practices. This includes expanded field support and access to Tiger’s extensive scientific and clinical data.

“Our goal is to provide dermatologists with best-in-class aesthetic innovations backed by scientific and clinical data,” said Oliver Burckhardt, Co-CEO of Tiger BioSciences. “This launch reflects our commitment to advancing dermatologic medicine and ensuring providers have the tools they need to deliver exceptional care, from complex wound management to restoring natural beauty and confidence.”

Tiger BioSciences’ placental wound care technologies and HealPack surgical dressings have been widely adopted across surgical and wound care settings. The addition of the company’s aesthetic portfolio creates a unified offering that supports dermatologists in both clinical and cosmetic practice areas.

About Tiger BioSciences

Tiger BioSciences, headquartered in Conshohocken, PA, is a vertically integrated cell and tissue technology company specializing in the recovery, processing, development, research, and distribution of cellular, acellular, and matrix‑like products (CAMPS) and aesthetic technologies. Built on a deep heritage of human cell and tissue processing expertise, the company functions as a tissue recovery agency, processing innovator, aesthetics device manufacturer, and commercial partner to clinicians, delivering cutting‑edge solutions that meet the evolving needs of providers and their patients and enabling life‑changing, head‑to‑toe treatment options across a wide range of applications. Tiger BioSciences remains steadfast in its commitment to patients, providers, and donor families.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tiger-biosciences-announces-launch-of-new-dermatology-division-expanding-access-to-advanced-wound-care-and-aesthetic-solutions-302652930.html

SOURCE Tiger BioSciences

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

MiCA Deadline Could Make Several French Crypto Firms Illegal

MiCA Deadline Could Make Several French Crypto Firms Illegal

The post MiCA Deadline Could Make Several French Crypto Firms Illegal appeared on BitcoinEthereumNews.com. French regulators announced this week that roughly 30
Share
BitcoinEthereumNews2026/01/17 05:29
The Transformative Yet Perilous Race Reshaping Medicine In 2025

The Transformative Yet Perilous Race Reshaping Medicine In 2025

The post The Transformative Yet Perilous Race Reshaping Medicine In 2025 appeared on BitcoinEthereumNews.com. AI Healthcare Gold Rush: The Transformative Yet Perilous
Share
BitcoinEthereumNews2026/01/17 05:17
IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge!

The post IP Hits $11.75, HYPE Climbs to $55, BlockDAG Surpasses Both with $407M Presale Surge! appeared on BitcoinEthereumNews.com. Crypto News 17 September 2025 | 18:00 Discover why BlockDAG’s upcoming Awakening Testnet launch makes it the best crypto to buy today as Story (IP) price jumps to $11.75 and Hyperliquid hits new highs. Recent crypto market numbers show strength but also some limits. The Story (IP) price jump has been sharp, fueled by big buybacks and speculation, yet critics point out that revenue still lags far behind its valuation. The Hyperliquid (HYPE) price looks solid around the mid-$50s after a new all-time high, but questions remain about sustainability once the hype around USDH proposals cools down. So the obvious question is: why chase coins that are either stretched thin or at risk of retracing when you could back a network that’s already proving itself on the ground? That’s where BlockDAG comes in. While other chains are stuck dealing with validator congestion or outages, BlockDAG’s upcoming Awakening Testnet will be stress-testing its EVM-compatible smart chain with real miners before listing. For anyone looking for the best crypto coin to buy, the choice between waiting on fixes or joining live progress feels like an easy one. BlockDAG: Smart Chain Running Before Launch Ethereum continues to wrestle with gas congestion, and Solana is still known for network freezes, yet BlockDAG is already showing a different picture. Its upcoming Awakening Testnet, set to launch on September 25, isn’t just a demo; it’s a live rollout where the chain’s base protocols are being stress-tested with miners connected globally. EVM compatibility is active, account abstraction is built in, and tools like updated vesting contracts and Stratum integration are already functional. Instead of waiting for fixes like other networks, BlockDAG is proving its infrastructure in real time. What makes this even more important is that the technology is operational before the coin even hits exchanges. That…
Share
BitcoinEthereumNews2025/09/18 00:32